REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 184 filers reported holding REGENXBIO INC in Q4 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,463,469 | -25.7% | 149,664 | -9.8% | 0.02% | -21.9% |
Q2 2023 | $3,316,621 | -3.9% | 165,914 | -9.1% | 0.03% | -8.6% |
Q1 2023 | $3,450,130 | +86.5% | 182,450 | +123.6% | 0.04% | +84.2% |
Q4 2022 | $1,850,212 | +139.0% | 81,579 | +178.6% | 0.02% | +111.1% |
Q3 2022 | $774,000 | +89.7% | 29,283 | +77.2% | 0.01% | +125.0% |
Q2 2022 | $408,000 | -81.5% | 16,522 | -72.5% | 0.00% | -83.3% |
Q2 2020 | $2,210,000 | +13.7% | 60,000 | 0.0% | 0.02% | -7.7% |
Q1 2020 | $1,943,000 | -21.0% | 60,000 | 0.0% | 0.03% | +18.2% |
Q4 2019 | $2,458,000 | +15.1% | 60,000 | 0.0% | 0.02% | +10.0% |
Q3 2019 | $2,136,000 | -30.7% | 60,000 | 0.0% | 0.02% | -28.6% |
Q2 2019 | $3,082,000 | +89.0% | 60,000 | +110.8% | 0.03% | +100.0% |
Q1 2019 | $1,631,000 | +37.1% | 28,461 | +0.3% | 0.01% | +27.3% |
Q4 2018 | $1,190,000 | -44.3% | 28,373 | +0.3% | 0.01% | -26.7% |
Q3 2018 | $2,135,000 | -26.0% | 28,281 | -29.7% | 0.02% | -25.0% |
Q2 2018 | $2,885,000 | +25.5% | 40,214 | -47.8% | 0.02% | +25.0% |
Q1 2018 | $2,298,000 | +17.1% | 77,000 | +30.5% | 0.02% | +23.1% |
Q4 2017 | $1,962,000 | – | 59,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |